Literature DB >> 8111061

Treatment approaches to the low-grade lymphomas.

S J Horning1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8111061

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Primary gastrointestinal follicular center lymphoma resembling multiple lymphomatous polyposis.

Authors:  Y Sakata; R Iwakiri; H Sakata; J Fujisaki; M Mizuguchi; N Fukushima; K Fujimoto
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.

Authors:  Steven I Park; Jaideep Shenoi; Shani M Frayo; Donald K Hamlin; Yukang Lin; D Scott Wilbur; Patrick S Stayton; Nural Orgun; Mark Hylarides; Franz Buchegger; Aimee L Kenoyer; Amanda Axtman; Ajay K Gopal; Damian J Green; John M Pagel; Oliver W Press
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

3.  Peripheral blood stem cell transplants.

Authors:  J L Byrne; N H Russell
Journal:  J Clin Pathol       Date:  1998-05       Impact factor: 3.411

4.  Follicular lymphoma with extensive gastrointestinal tract involvement: follow-up by capsule endoscopy.

Authors:  Boris Sapoznikov; Sarah Morgenstern; Pia Raanani; Adina Aviram; Esther Rabizadeh; Miron Prokocimer; Yaron Niv
Journal:  Dig Dis Sci       Date:  2007-03-13       Impact factor: 3.199

5.  Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.

Authors:  Damian J Green; John M Pagel; Eneida R Nemecek; Yukang Lin; Aimee Kenoyer; Anastasia Pantelias; Donald K Hamlin; D Scott Wilbur; Darrell R Fisher; Joseph G Rajendran; Ajay K Gopal; Steven I Park; Oliver W Press
Journal:  Blood       Date:  2009-06-10       Impact factor: 22.113

6.  Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma.

Authors:  S K Luthy; A K Ng; B Silver; K O Degnan; D C Fisher; A S Freedman; P M Mauch
Journal:  Ann Oncol       Date:  2008-07-22       Impact factor: 32.976

7.  Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.

Authors:  P J Woll; D Crowther; P W Johnson; M Soukop; P G Harper; M Harris; M H Brampton; E S Newlands
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

8.  Targeted radionuclide therapy.

Authors:  Devrim Ersahin; Indukala Doddamane; David Cheng
Journal:  Cancers (Basel)       Date:  2011-10-11       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.